Deciphera nabs speedy review for GIST cancer hopeful

Deciphera nabs speedy review for GIST cancer hopeful

Submitted by admin on February 13, 2020 - 10:49am
Source: 
Fierce Biotech
News Tags: 
Deciphera Pharma
FDA
priority review
ripretinib
GIST
Headline: 
Deciphera nabs speedy review for GIST cancer hopeful
snippet: 

Deciphera Pharmaceuticals has been handed a priority review from the FDA for its cancer drug ripretinib.

Do Not Allow Advertisers to Use My Personal information